APA

Verberne H. J., de Bruin K., Habraken J. B. A., Somsen G. A., Eersels J. L. H., Moet F., Booij J. & van Eck-Smit B. L. F. (20060919). No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. : European journal of nuclear medicine and molecular imaging.

Chicago

Verberne Hein J, de Bruin Kora, Habraken Jan B A, Somsen G Aernout, Eersels Jos L H, Moet Frits, Booij Jan and van Eck-Smit Berthe L F. 20060919. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. : European journal of nuclear medicine and molecular imaging.

Harvard

Verberne H. J., de Bruin K., Habraken J. B. A., Somsen G. A., Eersels J. L. H., Moet F., Booij J. and van Eck-Smit B. L. F. (20060919). No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. : European journal of nuclear medicine and molecular imaging.

MLA

Verberne Hein J, de Bruin Kora, Habraken Jan B A, Somsen G Aernout, Eersels Jos L H, Moet Frits, Booij Jan and van Eck-Smit Berthe L F. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. : European journal of nuclear medicine and molecular imaging. 20060919.